Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

Cells of the Adaptive Immune Response

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mutational Profile and Pathological Features of a Case of Interleukin-10 and RGS1-Positive Spindle Cell Variant Diffuse Large B-Cell Lymphoma.

Hematology reports·2023

Same author

Correction to: Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation.

Virchows Archiv : an international journal of pathology·2023

Same author

Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.

Leukemia·2023

Same author

Advances in the Classification of Myeloid and Lymphoid Neoplasms.

Virchows Archiv : an international journal of pathology·2022

Same author

Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.

Leukemia·2022

Same author

Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.

Leukemia·2022

Search research articles

Related Experiment Video

Updated: Jun 28, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

B-cell non-Hodgkin lymphomas.

Elisabeth Silkenstedt¹, Gilles Salles², Elias Campo³

¹Department of Medicine III, LMU Hospital, Munich, Germany.

Lancet (London, England)

|April 13, 2024

Summary

This summary is machine-generated.

Advances in understanding B-cell lymphomas, including new diagnostics and immunotherapies, have improved patient treatment. This review covers the biology, classification, and management of these diverse cancers.

More Related Videos

A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines

A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines

Published on: January 14, 2017

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Related Experiment Videos

Last Updated: Jun 28, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines

A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines

Published on: January 14, 2017

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Area of Science:

Hematology
Oncology
Immunology

Background:

B-cell lymphomas are diverse malignancies affecting any organ, with varying clinical presentations and courses.
Incidence is 20 per 100,000 in high-income countries.
Recent advances in understanding biology, diagnostics, and therapeutics have improved patient outcomes since 2017.

Purpose of the Study:

Provide an overview of the pathobiology, classification, and prognostication of B-cell non-Hodgkin lymphomas.
Summarize current knowledge and standard of care for common subtypes.
Highlight new findings in molecular background and immune-targeted therapies.

Main Methods:

Literature review and synthesis of recent research.
Analysis of pathobiology, classification, and prognostication data.
Summary of current therapeutic approaches, including targeted and immunotherapies.

Main Results:

Improved understanding of molecular mechanisms driving B-cell lymphoma development.
Implementation of novel diagnostic methods and targeted therapies.
Advancements in immunotherapeutic strategies, particularly immune system targeting.

Conclusions:

Significant progress has been made in treating B-cell lymphomas due to deeper biological insights and new therapeutic modalities.
Current standard of care integrates advanced diagnostics and targeted/immunotherapies.
Future research directions focus on further deciphering molecular backgrounds and refining immune-based treatments.